[1] Hou ZQ, Zhao JY, Mao XL,et al. Application and evaluation of Chinese medicine in treatment of chronic heart failure[J]. Chinese journal of integrated traditional and Western medicine,2013,33(12):1701-1704.
[2] 王贤良,袁杨,毛静远,等.优化新生脉散方联合西药治疗慢性心力衰竭单病例交叉随机对照研究[J].中医杂志,2015,56(21):1849-1853.
[3] Ge JM, Zhou K, Jiang XF, et al. Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts throughsuppressing interleukin-6.[J].Journal of cellular and molecular medicine,2015,19(5):1114-1121.
[4] 曹玉军,何昌生,杨国华. 生脉散加味治疗慢性充血性心力衰竭气阴两虚兼心脉瘀阻证临床观察[J]. 中国中医急症,2014,23(11):2003-2005.
[5] 尚芳红.中药新药加味佛手散胶囊的制剂及其药代动力学研究[D]. 长沙:中南大学,2015.
[6] 郑筱萸.中药新药治疗心力衰竭的临床研究指导原则[M].北京:中国医药科技出版社,2002.
[7] 黄美艳,唐于平,李伟霞,等.采用代谢组学策略研究佛手散对急性血瘀大鼠的活血化瘀作用机制[J].中国中药杂志,2013,38(20):3576-3582.
[8] Luo LW, Shi YM, Xie X,et al. Shengmai injection as an adjuvant treatment for chronic cor pulmonale heart failure: a systematic review and meta-analysis of randomized controlled trials[J]. BMC complementary and alternative medicine,2015,15(1):418.
[9] Liu JG, Xue XL, Wang Y,et al. Treatment of Chronic Heart Failure Patients with Qi-Yang Deficiency and Blood Stasis Resistance Syndrome by Xnmallong Injection: a Multi-center Randomized Control Study[J]. Chinese journal of integrated traditional and Western medicine,2015,35(7):796-800.
[10] 尚芳红,俸珊,张飞燕,等.加味佛手散及其配伍对大鼠肝脏P450酶活性及肝细胞形态的影响[J].中国中药杂志,2015,40(10):2030-2036.
[11] Li FY, Wang TZ, Yang SL,et al. Protection and mechanism of Qingyuan Shenghua decoction on multiple organs of sepsis patients after bone trauma[J]. Chinese journal of integrated traditional and Westernmedicine,2015,35(7):778-782.
[12] 詹琤琤.对慢性心衰大鼠应用生脉散进行治疗的效果研究[J]. 当代医药论丛,2015,4(6):45-45.
[13] 王恒和,程刚,刘兴磊. 新生脉散片对慢性心力衰竭患者近期疗效及血浆 BNP、AngⅡ、ALD 水平的影响[J].山东医药,2016,(5):59-61.